BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
44 auth. Frank J A van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R. Johnson, Murray Baron, Alan Tyndall, M. Matucci-Cerinic, R. Naden, Thomas A. Medsger, Patricia E. Carreira, G. Riemekasten, Philip J. Clements, C. Denton, Oliver Distler, Y. Allanore, ... D. Furst, Armando Gabrielli, Maureen D. Mayes, J. V. Van Laar, James R. Seibold, L. CzirjΓ‘k, Virginia D Steen, M. Inanc, O. Kowal-Bielecka, U. MΓΌller-Ladner, Gabriele Valentini, D. J. Veale, M. Vonk, Ulrich A. Walker, Lorinda Chung, David H. Collier, M. Csuka, B. Fessler, S. Guiducci, Ariane L. Herrick, V. Hsu, Sergio A. Jimenez, B. Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet E. Pope
9 2013
9
🐜
🐜 Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
44 auth. D. P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E Furst, D. Khanna, E. Kleerup, J. Goldin, E. Arriola, E. Volkmann, S. Kafaja, R. Silver, V. Steen, C. Strange, R. Wise, F. Wigley, ... M. Mayes, David J. Riley, S. Hussain, S. Assassi, V. Hsu, B. Patel, K. Phillips, F. Martinez, Jeff rey Golden, Kari Connolly, J. Varga, J. Dematte, M. Hinchcliff, A. Fischer, J. Swigris, R. Meehan, A. Theodore, R. Simms, S. Volkov, Dean E. Schraufnagel, M. Scholand, T. Frech, J. Molitor, K. Highland, Charles A Read, Marvin J. Fritzler, G. H. J. Kim, C. Tseng, R. Elashoff
9 2016
9
🐜
🐜 Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
34 auth. D. P. Tashkin, R. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, E. Arriola, Charlie Strange, M. Bolster, James R. Seibold, David J. Riley, V. Hsu, John Varga, Dean E. Schraufnagel, ... Arthur C. Theodore, Robert W. Simms, Robert A. Wise, F. Wigley, Barbara White, Virginia Steen, Charles A Read, Maureen D Mayes, E. Parsley, Kamal Mubarak, M. Connolly, Jeffrey A. Golden, Mitchell A. Olman, B. Fessler, Naomi F. Rothfield, M. Metersky, Dinesh Khanna, Ning Li, Gang Li
8 2007
8
🐜
🐜 The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
14 auth. Daniel E. Furst, Philip J. Clements, Philip J. Clements, V. Steen, V. Steen, Thomas A. Medsger, Thomas A. Medsger, Alfonse T. Masi, William A. D'Angelo, Peter A. Lachenbruch, ... Peter A. Lachenbruch, Rafael G. Grau, James R. Seibold, James R. Seibold
8 1998
8
🐜
🐜 The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
14 auth. Daniel E. Furst, Philip J. Clements, Philip J. Clements, V. Steen, V. Steen, Thomas A. Medsger, Thomas A. Medsger, Alfonse T. Masi, William A. D'Angelo, Peter A. Lachenbruch, ... Peter A. Lachenbruch, Rafael G. Grau, James R. Seibold, James R. Seibold
8 1998
8
🐜
🐒 Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study
25 auth. Dinesh Khanna, Daniel E. Furst, Ron D. Hays, Ron D. Hays, Grace S. Park, Weng Kee Wong, James R. Seibold, Maureen D Mayes, Barbara White, Barbara White, Fredrick Wigley, M. H. Weisman, Walter G. Barr, L. Moreland, Thomas A. Medsger, ... V. Steen, Richard W. Martin, David H. Collier, Arthur Weinstein, E. Lally, John Varga, Steven R. Weiner, B. Andrews, M. Abeles, Philip J. Clements
7 2006
7
🐒
🐜 Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
22 auth. D. Khanna, Philip J. Clements, Daniel E. Furst, Y. Chon, R. Elashoff, Michael D. Roth, M. Sterz, Jo-Hsuan Chung, John D FitzGerald, James R. Seibold, ... J. Varga, A. Theodore, F. Wigley, Richard M. Silver, Virginia Steen, Maureen D Mayes, M. Connolly, B. Fessler, Naomi F. Rothfield, K. Mubarak, J. Molitor, Donald P Tashkin
7 2005
7
🐜
🦁 The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
21 auth. Philip J. Clements, Weng Kee Wong, Eric L. Hurwitz, Daniel E. Furst, Maureen D Mayes, Barbara White, F. Wigley, Michael H. Weisman, Walter G. Barr, Larry W. Moreland, ... Thomas A. Medsger, Virginia Steen, Richard W. Martin, David H. Collier, Arthur Weinstein, E. Lally, John Varga, Steven R. Weiner, B. Andrews, M. Abeles, James R. Seibold
6 2001
6
🦁
🐬 A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?
Daniel E. Furst, Philip J. Clements, Peter Graze, R. Gale, Nigel K. Roberts
6 1979
6
🐬
🐜 Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis)
28 auth. Ken J. Bulpitt, Ken J. Bulpitt, Philip J. Clements, Philip J. Clements, Peter A. Lachenbruch, Peter A. Lachenbruch, Harold E. Paulus, Harold E. Paulus, James Peter, Mel Agopian, J. Z. Singer, J. Z. Singer, V. D. Steen, V. D. Steen, D. Clegg, ... C. Ziminski, C. Ziminski, Graciela S. AlarcΓ³n, Graciela S. AlarcΓ³n, M. Luggen, M. Luggen, R. P. Polisson, R. P. Polisson, R. Willkens, R. Willkens, J. Reading, H. Williams, J. Ward
6 1993
6
🐜
🐜 Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis)
28 auth. Ken J. Bulpitt, Ken J. Bulpitt, Philip J. Clements, Philip J. Clements, Peter A. Lachenbruch, Peter A. Lachenbruch, Harold E. Paulus, Harold E. Paulus, James Peter, Mel Agopian, J. Z. Singer, J. Z. Singer, V. D. Steen, V. D. Steen, D. Clegg, ... C. Ziminski, C. Ziminski, Graciela S. AlarcΓ³n, Graciela S. AlarcΓ³n, M. Luggen, M. Luggen, R. P. Polisson, R. P. Polisson, R. Willkens, R. Willkens, J. Reading, H. Williams, J. Ward
6 1993
6
🐜